Share this article on:

Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures

Johnson, Margaret; Grinsztejn, Beatriz; Rodriguez, Claudia; Coco, Jeffrey; DeJesus, Edwin; Lazzarin, Adriano; Lichtenstein, Kenneth; Rightmire, Anna; Sankoh, Serap; Wilber, Richard

Clinical Science

This paper has been removed from this issue because of typographical errors. The article was published in Volume 19(7), cover date 29 April 2005, pp. 685-694.

Cited By:

This article has been cited 3 time(s).

Antiretroviral drugs and liver injury
Soriano, V; Puoti, M; Garcia-Gascó, P; Rockstroh, JK; Benhamou, Y; Barreiro, P; McGovern, B
AIDS, 22(1): 1-13.
PDF (257) | CrossRef
JAIDS Journal of Acquired Immune Deficiency Syndromes
Rescue Therapy With Once-Daily Atazanavir-Based Regimens for Antiretroviral-Experienced HIV-Infected Patients
Dronda, F; Antela, A; Pérez-Elías, MJ; Casado, JL; Moreno, A; Moreno, S
JAIDS Journal of Acquired Immune Deficiency Syndromes, 42(2): 258-259.
PDF (184) | CrossRef
Pharmacogenetics and Genomics
Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy
Arnedo, M; Taffé, P; Sahli, R; Furrer, H; Hirschel, B; Elzi, L; Weber, R; Vernazza, P; Bernasconi, E; Darioli, R; Bergmann, S; Beckmann, JS; Telenti, A; Tarr, PE; the Swiss HIV Cohort Study,
Pharmacogenetics and Genomics, 17(9): 755-764.
PDF (145) | CrossRef
Back to Top | Article Outline
© 2005 Lippincott Williams & Wilkins, Inc.